Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion type Assertion NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_head.
- NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_provenance.
- NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion evidence source_evidence_literature NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_provenance.
- NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion SIO_000772 22271902 NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_provenance.
- NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion wasDerivedFrom befree-20140225 NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_provenance.
- NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion wasGeneratedBy ECO_0000203 NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_provenance.